273 related articles for article (PubMed ID: 9469643)
1. The effects of a newly developed nonsteroidal anti-inflammatory drug (M-5011) on arachidonic acid metabolism in rheumatoid synovial fibroblasts.
Tobetto K; Yamamoto Y; Kataoka M; Ando T; Sugimoto K; Himeno M
Jpn J Pharmacol; 1997 Dec; 75(4):371-9. PubMed ID: 9469643
[TBL] [Abstract][Full Text] [Related]
2. Effects of non-steroidal anti-inflammatory drugs on prostaglandin E2 production by cyclooxygenase-2 from endogenous and exogenous arachidonic acid in rat peritoneal macrophages stimulated with lipopolysaccharide.
Nakatsugi S; Sugimoto N; Furukawa M
Prostaglandins Leukot Essent Fatty Acids; 1996 Dec; 55(6):451-7. PubMed ID: 9014225
[TBL] [Abstract][Full Text] [Related]
3. Aceclofenac blocks prostaglandin E2 production following its intracellular conversion into cyclooxygenase inhibitors.
Yamazaki R; Kawai S; Matsuzaki T; Kaneda N; Hashimoto S; Yokokura T; Okamoto R; Koshino T; Mizushima Y
Eur J Pharmacol; 1997 Jun; 329(2-3):181-7. PubMed ID: 9226412
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate and cyclooxygenase metabolism in cultured human rheumatoid synoviocytes.
Vergne P; Liagre B; Bertin P; Cook-Moreau J; Treves R; Beneytout JL; Rigaud M
J Rheumatol; 1998 Mar; 25(3):433-40. PubMed ID: 9517759
[TBL] [Abstract][Full Text] [Related]
6. Hydrolytic activity is essential for aceclofenac to inhibit cyclooxygenase in rheumatoid synovial cells.
Yamazaki R; Kawai S; Matsumoto T; Matsuzaki T; Hashimoto S; Yokokura T; Okamoto R; Koshino T; Mizushima Y
J Pharmacol Exp Ther; 1999 May; 289(2):676-81. PubMed ID: 10215639
[TBL] [Abstract][Full Text] [Related]
7. Differential inhibition of murine prostaglandin synthase-1 and -2 by nonsteroidal anti-inflammatory drugs using exogenous and endogenous sources of arachidonic acid.
Chulada PC; Langenbach R
J Pharmacol Exp Ther; 1997 Feb; 280(2):606-13. PubMed ID: 9023270
[TBL] [Abstract][Full Text] [Related]
8. Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells.
Kawai S; Nishida S; Kato M; Furumaya Y; Okamoto R; Koshino T; Mizushima Y
Eur J Pharmacol; 1998 Apr; 347(1):87-94. PubMed ID: 9650852
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory, analgesic and anti-pyretic effects of d-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid (M-5011), a new non-steroidal anti-inflammatory drug, in rats and guinea pigs.
Kido H; Murakami N; Ito A; Kimura K; Kodera N; Doi T; Naruse T
Jpn J Pharmacol; 1998 Jan; 76(1):75-86. PubMed ID: 9517407
[TBL] [Abstract][Full Text] [Related]
10. Involvement of cyclooxygenase-2 in interleukin-1alpha-induced prostaglandin production by human periodontal ligament cells.
Noguchi K; Shitashige M; Ishikawa I
J Periodontol; 1999 Aug; 70(8):902-8. PubMed ID: 10476899
[TBL] [Abstract][Full Text] [Related]
11. In vitro based index of topical anti-inflammatory activity to compare a series of NSAIDs.
Cordero JA; Camacho M; Obach R; Domenech J; Vila L
Eur J Pharm Biopharm; 2001 Mar; 51(2):135-42. PubMed ID: 11226820
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 inhibitors decrease interleukin-1beta-stimulated prostaglandin E2 and IL-6 production by human gingival fibroblasts.
Tipton DA; Flynn JC; Stein SH; Dabbous MKh
J Periodontol; 2003 Dec; 74(12):1754-63. PubMed ID: 14974816
[TBL] [Abstract][Full Text] [Related]
13. Preferential inhibition of cyclooxygenase-2 by meloxicam in human rheumatoid synoviocytes.
Tsubouchi Y; Sano H; Yamada R; Hashiramoto A; Kohno M; Kusaka Y; Kondo M
Eur J Pharmacol; 2000 May; 395(3):255-63. PubMed ID: 10812057
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts.
Kojima F; Naraba H; Sasaki Y; Beppu M; Aoki H; Kawai S
Arthritis Rheum; 2003 Oct; 48(10):2819-28. PubMed ID: 14558087
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of aceclofenac and its metabolites on the production by chondrocytes of inflammatory mediators.
Henrotin Y; de Leval X; Mathy-Hartet M; Mouithys-Mickalad A; Deby-Dupont G; Dogné JM; Delarge J; Reginster JY
Inflamm Res; 2001 Aug; 50(8):391-9. PubMed ID: 11556519
[TBL] [Abstract][Full Text] [Related]
16. Participation of cyclooxygenase-1 in prostaglandin E2 release from synovitis tissue in primary osteoarthritis in vitro.
Knorth H; Dorfmüller P; Lebert R; Schmidt WE; Wittenberg RH; Heukamp M; Wiese M; Willburger RE
Osteoarthritis Cartilage; 2004 Aug; 12(8):658-66. PubMed ID: 15262246
[TBL] [Abstract][Full Text] [Related]
17. The molecular mechanism of inhibition of interleukin-1beta-induced cyclooxygenase-2 expression in human synovial cells by Tripterygium wilfordii Hook F extract.
Maekawa K; Yoshikawa N; Du J; Nishida S; Kitasato H; Okamoto K; Tanaka H; Mizushima Y; Kawai S
Inflamm Res; 1999 Nov; 48(11):575-81. PubMed ID: 10598013
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-4 inhibits prostaglandin E2 production by freshly prepared adherent rheumatoid synovial cells via inhibition of biosynthesis and gene expression of cyclo-oxygenase II but not of cyclo-oxygenase I.
Sugiyama E; Taki H; Kuroda A; Mino T; Yamashita N; Kobayashi M
Ann Rheum Dis; 1996 Jun; 55(6):375-82. PubMed ID: 8694577
[TBL] [Abstract][Full Text] [Related]
20. Stereoselective inhibition of inducible cyclooxygenase by chiral nonsteroidal antiinflammatory drugs.
Carabaza A; Cabré F; Rotllan E; Gómez M; Gutiérrez M; García ML; Mauleón D
J Clin Pharmacol; 1996 Jun; 36(6):505-12. PubMed ID: 8809635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
